n the Philippines, a new subvariant of COVID-19, named JN.1, has been identified, with 18 cases confirmed through genomic sequencing. The Department of Health (DOH) reported that these cases, detected between November 16 and December 3, have all recovered. Despite the emergence of this subvariant, there hasn’t been a notable increase in the severity or number of cases. JN.1 is categorized as an Omicron subvariant and, according to the DOH, it does not exhibit increased severity or unusual clinical presentation, nor does it appear to spread more rapidly.
The World Health Organization (WHO) has classified JN.1 as a “currently circulating variant of interest” within its parent lineage BA.2.86. However, the global public health risk posed by JN.1 is currently considered low. As of December 23, JN.1 accounted for a substantial percentage of cases in the United States and has also been detected in China. The WHO and epidemiologists are closely monitoring and studying this variant.
Amid rising COVID-19 cases, Dr. Tony Leachon, a public health advocate, suggested making face masks mandatory in enclosed spaces for at least two weeks. Dr. Leachon noted that infections are likely to peak soon, exacerbated by holiday activities such as travel, shopping, and church visits. He expressed concerns that JN.1 might contribute to the spike in cases. The Health Secretary also urged the public to wear face masks, emphasizing the importance of multiple layers of protection during this period.